Back

Beta-blocker therapy and risk of dementia: a population-based prospective study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Use benefit and risk of pharmacotherapy Beta-Blockers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hannes Holm

Skane University Hospital, Malmo (Sweden)

6 More presentations in this session

Presentation thumbnail
Research network in Africa (RNA) : antihypertensive drugs strategies in 12 African countries
Professor A. Kane (Saint-Louis, SN)
Abstract Slides
Presentation thumbnail
Comparison of effects of lowering blood pressure in individuals with blood pressure <140/90 mmHg and hypertension guideline recommendations: a systematic review and meta-analysis of randomised trials
Doctor A. Mohammad (Hyderabad, IN)
Abstract
Presentation thumbnail
Thiazides and skin cancer risk: should we be worried?
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Amlodipine induces vasodilation via Akt2/Sp1-activated miR-21 in smooth muscle cells
Professor C. Chen (Wuhan, CN)
Presentation thumbnail
Cardiovascular toxicity of ibrutinib: a pharmacovigilance study.
Professor J. Salem (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Use benefit and risk of pharmacotherapy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
thumbnail
Congress Presentation
Impact of beta-blocker therapy in patients with preserved left ventricular ejection fraction after ST-segment elevation myocardial infarction
thumbnail
Congress Presentation
Beta-blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources